UPDATE: Ladenburg Thalmann Raises PT to $16.50 on BG Medicine - BG Medicine (OTC:BGMD)

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

Ladenburg Thalmann raises its price target on Buy-rated BG Medicine (NASDAQ: BGMD) to $16.50 from $8.25 a share on strong top-line data for CardioSCORE. Ladenburg Thalmann says, "Based on the 2x improvement in predictive power for CardioSCORE over the current gold standard (Framingham Risk Score) and large size of the validation cohort, we believe CardioSCORE has established a firm footing for clinical utility as a screening tool. As such, we are adding the test to our revenue forecast with peak gross sales of $325M. The impact of CardioSCORE economics raises our base year EPS estimate (2017) from $0.71 to $1.42."BGMD closed at $8.27 a share on Monday.

Crypto Whales Are Loading Up — Are You?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!